Loading...
Effectiveness of Angiotensin Receptor Blockers (ARB) and hydrochlorothiazide compared to ARB monotherapy in the control of hypertension among adult patients: A systematic review and meta-analysis
Agwu, Anthony O. Egwu, Chinedu O. Oyinloye, Inigbehe B. Chukwu, Jennifer
Agwu, Anthony O.
Egwu, Chinedu O.
Oyinloye, Inigbehe B.
Chukwu, Jennifer
Advisors
Editors
Other Contributors
EPub Date
Publication Date
2024-11-26
Submitted Date
Collections
Files
Loading...
Article - VoR
Adobe PDF, 1.62 MB
Other Titles
Abstract
Background: Hypertension (HTN) is a global disease of public health concern. It is considered a major cause of morbidity and mortality worldwide. The global and regional recommendations for the management of high blood pressure are complicated, with an increasing call for several adequate measures to commence treatment, increase the dosage, or introduce a new class of medication. Evidence suggests that most people with HTN require more than one drug regime to achieve blood pressure goals, with a greater percentage of patients reporting only having access to monotherapy. This work evaluated the combined effectiveness of angiotensin receptor blockers (ARBs) and hydrochlorothiazide (HCTZ) compared to ARB monotherapy in an uncontrolled hypertensive patients. Methods: The search involved screening through databases such as Cochrane Library, PubMed, CINAHL, Embase, Medline, and the Web of Science, medical journals, and international registry on clinicals from the WHO were searched for primary studies not older than 13 years. Randomized control trials (RCTs) comparing the effectiveness of ARB/HCTZ versus ARB monotherapy in hypertensive patients were selected. Care was taken to include only studies that lasted at least four weeks. Meta-analysis was conducted on RevMan 5.3 statistical application software, following data extraction. Data quality and risk of bias assessment were also all assessed. A total of seven RCTs were considered for this study involving 4814 participants. Results: The result from the intervention arm revealed that ARB/HCTZ combination resulted in a higher rate of target blood pressure achievement when compared to ARB monotherapy relative risk (RR) = 1.53, 95% confidence interval (CI) (1.42, 1.65), with p < 0.00007. The adverse effects observed in the intervention arm were not significant. Conclusion: The ARB/HCTZ combination therapy was more effective in lowering and controlling blood pressure when compared to ARB monotherapy without significant adverse drug effects reported by the participants. Health workers should therefore recommend ARB/HCTZ combination therapy for patients with uncontrolled hypertension.
Citation
Agwu, A. O., Egwu, C. O., Oyinloye, I. B., & Chukwu, J. (2024). Effectiveness of Angiotensin Receptor Blockers (ARB) and Hydrochlorothiazide compared to ARB Monotherapy in the control of Hypertension among adult patients: A systematic review and meta-analysis. Journal of Molecular and Clinical Medicine, 7(1), 1. https://doi.org/10.31083/j.jmcm0701001
Publisher
IMR Press
Journal
Journal of Molecular and Clinical Medicine
Research Unit
DOI
10.31083/j.jmcm0701001
PubMed ID
PubMed Central ID
Type
Article
Language
Description
Copyright: © 2024 The Author(s). Published by IMR Press.
Series/Report no.
ISSN
2616-3632
EISSN
2617-5282
ISBN
ISMN
Gov't Doc
Test Link
Sponsors
Unfunded